Effect of Glyburide vs Subcutaneous Insulin on Perinatal Complications Among Women With Gestational Diabetes: A Randomized Clinical Trial
(Abstracted from JAMA 2018;319(17):1773–1780)
Gestational diabetes continues to increase nationally and globally. The American Diabetes Association currently recommends insulin, the only Food and Drug Administration–approved pharmacologic agent, as first-line treatment for women with gestational diabetes mellitus requiring medications.
Source: Obstetrical and Gynecological Survey - Category: OBGYN Tags: Obstetrics: Medical Complications of Pregnancy Source Type: research
More News: Clinical Trials | Diabetes | Diabetes Mellitus | Endocrinology | Glyburide | Insulin | OBGYN | Perinatology & Neonatology | Pregnancy | Women